William Blair & Company
AUGX

William Blair & Company’s Augmedix, Inc. Common Stock AUGX Stock Holding History

William Blair & Company’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-221,749
Closed -$195K – 1884
2024
Q2 		$195K Buy
221,749
+24,295
+12% +$50.1K ﹤0.01% 1418
2024
Q1 		$808K Buy
197,454
+46,265
+31% +$207K ﹤0.01% 931
2023
Q4 		$884K Buy
151,189
+53,150
+54% +$280K ﹤0.01% 894
2023
Q3 		$505K Sell
98,039
-46,158
-32% -$217K ﹤0.01% 1058
2023
Q2 		$694K Sell
144,197
-30,400
-17% -$105K ﹤0.01% 958
2023
Q1 		$304K Sell
174,597
-24,441
-12% -$39.9K ﹤0.01% 1234
2022
Q4 		$310K Sell
199,038
-6,525
-3% -$8.31K ﹤0.01% 1217
2022
Q3 		$298K Buy
205,563
+89,797
+78% +$154K ﹤0.01% 1234
2022
Q2 		$208K Sell
115,766
-9,059
-7% -$21K ﹤0.01% 1406
2022
Q1 		$367K Buy
124,825
+106,400
+577% +$289K ﹤0.01% 1282
2021
Q4 		$58K Buy
+18,425
New +$66.8K ﹤0.01% 1760

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

William Blair & Company's AUGX Position: Q3 2024 in Review

William Blair & Company sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 221,749 shares — an estimated $195K sold.

William Blair & Company first reported a position in AUGX in Q4 2021 and held it in 11 quarters. The position peaked at $884K in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • William Blair & Company reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • William Blair & Company sold 221,749 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $195K.
  • William Blair & Company first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • William Blair & Company's Augmedix, Inc. Common Stock position peaked at $884K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on William Blair & Company's 13F filing for Q3 2024, filed 12 Nov 2024.